126 related articles for article (PubMed ID: 33210330)
1. Limited immunoexpression of fibroblast growth factor receptor 2 (FGFR2) in digital papillary adenocarcinoma: Comparison of FGFR2 immunohistochemistry between digital papillary adenocarcinoma, other sweat gland tumors and normal skin tissue.
Satake K; Goto K; Sugino T; Sasaki Y; Yoshikawa S; Kiyohara Y
J Dermatol; 2021 Feb; 48(2):e86-e87. PubMed ID: 33210330
[No Abstract] [Full Text] [Related]
2. Value of Immunohistochemistry to Differentiate Digital Papillary Adenocarcinoma From Acral Hidradenoma With Papillary Structures.
Xavier-Júnior JCC; Camilo-Júnior DJ; Carneiro Dias AL; Marques Ferreira PP; Abdalla Filho AR; Brenn T
Am J Dermatopathol; 2022 Nov; 44(11):843-845. PubMed ID: 36066118
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma.
Surowy HM; Giesen AK; Otte J; Büttner R; Falkenstein D; Friedl H; Meier F; Petzsch P; Wachtmeister T; Westphal D; Wieczorek D; Wruck W; Adjaye J; Rütten A; Redler S
Br J Dermatol; 2019 May; 180(5):1150-1160. PubMed ID: 30472730
[TBL] [Abstract][Full Text] [Related]
4. Aggressive digital papillary adenocarcinoma presenting as a paronychia of the finger.
Gorva AD; Mohil R; Srinivasan MS
J Hand Surg Br; 2005 Oct; 30(5):534. PubMed ID: 16055244
[TBL] [Abstract][Full Text] [Related]
5. Aggressive digital papillary adenocarcinoma of the hand: an unsuspected malignant tumour of the sweat glands.
Martínez Villén G; Alvarez Alegret R; Canales V; Herrera A
J Plast Surg Hand Surg; 2012 Sep; 46(3-4):294-6. PubMed ID: 22747355
[TBL] [Abstract][Full Text] [Related]
6. Aggressive Digital Papillary Adenocarcinoma Initially Misdiagnosed as Basal Cell Carcinoma.
Chen ELA; Nijhawan RI
Dermatol Surg; 2021 Jan; 47(1):137-139. PubMed ID: 31567583
[No Abstract] [Full Text] [Related]
7. Aggressive digital papillary adenoma.
Viroslav S; Finan MC; Smith JW
Orthopedics; 1996 Oct; 19(10):899-900. PubMed ID: 8905867
[No Abstract] [Full Text] [Related]
8. Tender finger nodule.
Klapperich ME; Buhalog BA; Hinshaw MA
Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906012
[TBL] [Abstract][Full Text] [Related]
9. Hidradenoma papilliferum of nasal skin.
Smith FB; Shemen LJ; Guerrieri C; Ismail SS
Arch Pathol Lab Med; 2003 Feb; 127(2):E86-8. PubMed ID: 12562260
[TBL] [Abstract][Full Text] [Related]
10. Aggressive digital papillary adenocarcinoma: a case report and review of the literature.
Jih DM; Elenitsas R; Vittorio CC; Berkowitz AR; Seykora JT
Am J Dermatopathol; 2001 Apr; 23(2):154-7. PubMed ID: 11285414
[TBL] [Abstract][Full Text] [Related]
11. Update on Malignant Sweat Gland Tumors.
van der Horst MPJ; Brenn T
Surg Pathol Clin; 2017 Jun; 10(2):383-397. PubMed ID: 28477887
[TBL] [Abstract][Full Text] [Related]
12. A 46-year-old man with an enlarging finger nodule.
Kantrow SM; Stumph JF; Zanolli MD; Wright JE
Arch Pathol Lab Med; 2005 Aug; 129(8):e179-80. PubMed ID: 16048414
[No Abstract] [Full Text] [Related]
13. Clinicopathologic Characterization of Hidradenoma on Acral Sites: A Diagnostic Pitfall With Digital Papillary Adenocarcinoma.
Wiedemeyer K; Gill P; Schneider M; Kind P; Brenn T
Am J Surg Pathol; 2020 May; 44(5):711-717. PubMed ID: 31876586
[TBL] [Abstract][Full Text] [Related]
14. Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited).
Duke WH; Sherrod TT; Lupton GP
Am J Surg Pathol; 2000 Jun; 24(6):775-84. PubMed ID: 10843279
[TBL] [Abstract][Full Text] [Related]
15. [Digital papillary adenocarcinoma : Four case reports with brief literature review].
Held L; Mentzel T; Paredes BE; Griewank KG; Itzlinger-Monshi B; Rütten A
Hautarzt; 2019 Mar; 70(3):204-209. PubMed ID: 30478600
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
Iijima M; Nakayama J; Nishizawa T; Ishida A; Ishii K; Ota H; Katsuyama T; Saida T
Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.
Tokunaga R; Imamura Y; Nakamura K; Ishimoto T; Nakagawa S; Miyake K; Nakaji Y; Tsuda Y; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Saeki H; Yoshida N; Oki E; Watanabe M; Oda Y; Bass AJ; Maehara Y; Baba H
Oncotarget; 2016 Apr; 7(15):19748-61. PubMed ID: 26933914
[TBL] [Abstract][Full Text] [Related]
18. Syringadenocarcinoma papilliferum.
Numata M; Hosoe S; Itoh N; Munakata Y; Hayashi S; Maruyama Y
J Cutan Pathol; 1985 Feb; 12(1):3-7. PubMed ID: 2982933
[TBL] [Abstract][Full Text] [Related]
19. [Sweat gland carcinomas of the skin].
Rütten A; Requena L
Hautarzt; 2008 Feb; 59(2):151-60. PubMed ID: 18214401
[TBL] [Abstract][Full Text] [Related]
20. Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations.
Kao GF; Helwig EB; Graham JH
J Cutan Pathol; 1987 Jun; 14(3):129-46. PubMed ID: 3301927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
